18F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: Comparative study with 18F-FDG PET and immunohistochemistry

Annals of Nuclear Medicine

Volumn 24, Issue 8, 2010, Pages 579-584

  Miyashita, Go ^a   Higuchi, Tetsuya ^a   Oriuchi, Noboru ^a   Arisaka, Yukiko ^a   Hanaoka, Hirofumi ^a   Tominaga, Hideyuki ^a   Morita, Satoshi ^b   Miyakubo, Mitsuyuki ^a   Ishikita, Tomohiro ^a   Nakasone, Yoshiki ^a   Negishi, Akihide ^a   Yokoo, Satoshi ^a   Endo, Keigo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

18F FDG; Ki 67; l 3 18F fluoro methyl tyrosine; LAT1; Oral squamous cell carcinoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; KI 67 ANTIGEN; LEVO 3 FLUORO ALPHA METHYL TYROSINE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; DRUG DERIVATIVE; O (18F)FLUOROMETHYL L TYROSINE; O-(18F)FLUOROMETHYL-L-TYROSINE; TYROSINE;

AGED; ARTICLE; CANCER SURGERY; CELL PROLIFERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; DRUG UPTAKE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MALE; MOUTH CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SQUAMOUS CELL CARCINOMA; STAINING; TUMOR GROWTH; ADULT; CLINICAL TRIAL; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PROSPECTIVE STUDY; SCINTISCANNING; TRANSPORT AT THE CELLULAR LEVEL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL TRANSPORT; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; TYROSINE;

EID: 78149409642     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-010-0398-2     Document Type: Article

References (21)

1. Stewart BW, Kleihues P, editors. World cancer report. Lyon: WHO International Agency for Research on Cancer; 2003.
2. Y Nakasone T Inoue N Oriuchi K Takeuchi A Negishi K Endo, et al. 2001 The role of whole-body FDG-PET in preoperative assessment of tumor staging in oral cancers Ann Nucl Med 15 505 512 1:STN:280:DC%2BD387gtVGgtw%3D%3D 10.1007/BF02988503 11831398
3. 18F]-fluoro-α- methyltyrosine (FMT) PET: a comparative study with FDG-PET Ann Nucl Med 21 129 135 1:CAS:528:DC%2BD2sXmtVCnt7k%3D 10.1007/BF03033991 17424980
4. SD Rege L Chaiken CK Hoh Y Choi R Lufkin Y Anzai, et al. 1993 Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET Radiology 189 807 812 1:STN:280:DyaK2c%2Flt1KisA%3D%3D 8234708
5. 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer. Mol Imaging Eur J Nucl Med 34 1610 1616 1:CAS:528:DC%2BD2sXhtVOit7bF 10.1007/s00259-007-0449-7
6. 18F-FDG J Nucl Med 189 807 812
7. 18F-FDG in primary head and neck cancer correlates with survival Nuklearmedizin 47 80 85 1:STN:280:DC%2BD1cvhtFyntg%3D%3D 18392317
8. T Inoue K Koyama N Oriuchi S Alyafei Z Yuan H Suzuki, et al. 2001 Detection of malignant tumors: whole-body PET with fluorine 18 alpha-methyl tyrosine versus FDG-preliminary study Radiology. 220 54 62 1:CAS:528: DC%2BD3MXltFWktLY%3D 11425972
9. K Kaira N Oriuchi Y Otani K Shimizu S Tanaka H Imai, et al. 2007 Fluorine-18-A-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study Clin Cancer Res 13 6369 6378 1:CAS:528:DC%2BD2sXht1Cgtb%2FE 10.1158/1078-0432.CCR-07-1294 17975149
10. K Kaira N Oriuchi H Imai K Shimizu N Yanagitani N Sunaga, et al. 2009 Prognostic significance of l-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma Lung Cancer 66 120 126 10.1016/j.lungcan.2008.12.015 19171406
11. 18F alpha-methyl tyrosine positron-emission tomography Neuroradiology 45 700 707 1:STN:280: DC%2BD3svos1Sqtg%3D%3D 10.1007/s00234-003-1057-2 13680026
12. H Imai K Kaira N Oriuchi N Yanagitani N Sunaga T Ishizuka, et al. 2009 l-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer Histopathology 54 804 813 10.1111/j.1365-2559.2009.03300.x 19635099
13. K Watanabe H Nomori T Ohtsuka T Naruke A Ebihara H Orikasa, et al. 2006 [F-18] Fluorodeoxyglucose Positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas Jpn J Clin Oncol 36 403 409 10.1093/jjco/hyl043 16782729
14. H Vesselle RA Schmidt JM Pugsley M Li SG Kohlmeyer E Valliéres, et al. 2000 Lung cancer proliferation correlates with [F-18] fluorodeoxyglucose uptake by positron emission tomography Clin Cancer Res 6 3837 3844 1:CAS:528:DC%2BD3cXotVyktLo%3D 11051227
15. K Higashi Y Ueda M Yagishita Y Arisaka A Sakurai M Oguchi, et al. 2000 FDG PET measurement of the proliferative potential of non-small cell lung cancer J Nucl Med 41 85 92 1:STN:280:DC%2BD3c7ht1Wgtw%3D%3D 10647609
16. R Jacob HJ Welkoborsky WJ Mann M Jauch R Amedee 2001 [Fluorine-18] fluorodeoxyglucose positron emission tomography, DNA ploidy and growth fraction in squamous-cell carcinomas of the head and neck ORL J Otorhinolaryngol Relat Spec 63 307 313 1:STN:280:DC%2BD3Mvos1ajsQ%3D%3D 11528276
17. H Minn M Lapela PJ Klemi R Grénman S Leskinen P Lindholm, et al. 1997 Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer J Nucl Med 38 1907 1911 1:STN:280:DyaK1c%2FptVegsA%3D%3D 9430467
18. 18F-alpha-methyltyrosine using a separation and purification system Nucl Med Commun 18 169 175 1:CAS:528:DyaK2sXhvFygsr0%3D 10.1097/00006231-199702000-00013 9076774
19. 18FDG) uptake measured by positron emission tomography is associated with reduced overall survival in patients with oral squamous cell carcinoma Oral Oncol 45 963 967 10.1016/j.oraloncology.2009.06.008 19665923
20. 18F-FMT uptake seen within primary cancer on PET helps predict outcome of non-small cell lung cancer J Nucl Med 50 1770 1776 10.2967/jnumed.109.066837 19837768
21. H Myoung MJ Kim JH Lee YJ Ok JY Paeng PY Yun 2006 Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patients Int J Oral Maxillofac Surg 35 1005 1010 1:STN:280: DC%2BD28njsVKjsw%3D%3D 10.1016/j.ijom.2006.07.016 17018251